Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
WAYNE, Pa., March 02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel...
-
Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U)...
-
Austin, TEXAS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MOZAYYX Acquisition Corp. (NYSE: MZYX.U) (the “Company”) today announced that it closed its upsized initial public offering of 30,000,000 units at...
-
BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients...
-
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Middlefield, on behalf of MRF 2026 Resource Limited Partnership (“MRF 2026” or the “Partnership”), is pleased to announce that it has completed the first...
-
Birchtech Announces Pricing of $15 Million Public Offering and Uplisting to NYSE American Stock Exchange
-
BALA CYNWYD, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare...
-
WYOMISSING, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (“GLPI”) (NASDAQ: GLPI) today announced the pricing of a public offering of $800,000,000 aggregate principal...
-
BOCA RATON, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- ClearThink 1 Acquisition Corp. (NASDAQ: CTAAU) (the "Company") today announced the closing of its initial public offering of 12,500,000 units at...
-
BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients...